Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 33 34 35 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
TAKTIC project–EU (govt): grant, 201304– FP7 grant €1.1m 2013-04-01
Univ Bremen–DFG (DE): grant, 201304– Core Facility grant 3 years up to €450k for MALDI-MULTI MALDI Imaging Core Facility 2013-04-01
CureVac–Russo Partners: public relations, 201303 service existent by Russo Partners LLC 2013-03-27
Medicyte–Life Technologies: lentiviral vector technology, 201303– license €na to develop + market upcyte cell products 2013-03-27
Transcatheter Technologies–High-Tech Gründerfonds: investment, 201303 financing round Series B totalling €2.6m incl returning investor HTGF 2013-03-27
Transcatheter Technologies–SEVERAL: investment, 201303 financing round Series B €2.6m lead investor Rolf Käse 2013-03-27
Innopsys–Scienion: microarray technology, 201303– collab product integration of sciFlexarrayer + InnoScan scanners to offer integrated solutions 2013-03-25
Biofrontera–Maruho: investment, 201303 capital increase €7.534m net €7.475m 1.61m new shares sold to Maruho Deutschland GmbH 2013-03-22
Partners HealthCare–Ingenuity Systems: genomic software tools, 201303– collab on integrated workflow solution for genetic testing labs GeneInsight 2013-03-19
Boehringer–HB Technologies: software solutions, 201303 supply existent Boehringer Ingelheim listed as life science customer 2013-03-18
Danaher–Leco: mass spectrometer, 201303– collab co-marketing of GC/MS + LC/MS Solutions for metabolomics in North America + Europe AB Sciex 2013-03-18
Direvo Industrial Biotechnology–SEVERAL: investment, 201303 3rd financing round €3.5m incl all current investors 2013-03-18
Eppendorf–HB Technologies: software solutions, 201303 supply existent Eppendorf listed as life science customer 2013-03-18
Eurofins–HB Technologies: software solutions, 201303 supply existent Eurofins listed as life science customer 2013-03-18
HB Technologies–Eagle Genomics: bioinformatics, 201303– collab excl distribution in DE + AT + CH + LU by HB Technologies 2013-03-18
Microsynth–HB Technologies: software solutions, 201303 supply existent Microsynth listed as life science customer 2013-03-18
Qiagen–HB Technologies: software solutions, 201303 supply existent Qiagen listed as life science customer 2013-03-18
Roche–HB Technologies: software solutions, 201303 supply existent Roche listed as life science customer 2013-03-18
Novartis–ThromboGenics: ocriplasmin, 201203– 201709 commercialisation rights for Jetrea outside US to Alcon €75m upfront + €300m ms TERMINATED 9/17 2013-03-16
Qurient–Max Planck: kinase inhibitor, 201303– license ww excl to Axl kinase inhibitors from LDC 2013-03-12
CytoTools–SEVERAL: investment, 201303 capital increase €3.7m 170k new shares €21.8/share to institutional investors 2013-03-06
Elitech–Curetis: Unyvero platform, 201303– distribution by Elitech BNL (formerly Lucron Bioproducts) in Belgium + Luxembourg 2013-03-06
Evolva–Cargill: investment, 201303 equity investment CHF5m in connection with collaboration on steviol glycosides 2013-03-06
Evolva–SEVERAL: investment, 201303 capital increase CHF31.3m with 52.2m new shares CHF0.6/share 2013-03-06
AdvanceCor–SEVERAL: investment, 201303 financing round €6.5m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank 2013-03-01
Harrison Clinical Research–Synteract: investment, 201303 acquisition merger €na of HCR + Synteract into SynteractHCR 2013-03-01
IFAMM project–EU (govt): grant, 201301–201702 FP7 grant €9m out of €12.25m total project cost 2013-03-01
Optimare–Aerodata: investment, 201303 acquisition €na of bankrupt Optimare Group by Aerodata AG 2013-03-01
EpiTherapeutics–Merck (DE): investment, 201302 financing round Series A 1st closing totalling €5m incl returning investor Merck Serono Ventures 2013-02-27
EpiTherapeutics–SEVERAL: investment, 201302 financing round Series A 1st closing of €5m incl Novo Seeds + MS Ventures et al. 2013-02-27
Sartorius–Aber Instruments: sensor technology, 201302– co-developm + excl ww marketing + distribution of single-use sensors to biopharma market by SSB 2013-02-27
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201302– collab Thermo edition of established AbsoluteIDQ p150 kit for TSQ Vantage Triple Quad MS 2013-02-27
Advion–CAMAG: thin-layer chromatography, 201302– OEM distribution excl of CAMAG’s TLC/MS interface with expression CMS by Advion 2013-02-26
Leo Pharma–4SC: drug discovery services, 201302– collab €1m upfront + €95m milestones + royalties r+d + commerc drugs for inflammatory skin diseases 2013-02-26
Univ Gießen–Advion: mass spectrometer, 201302 supply existent expression CMS with CAMAG TLC/MS Interface used by Prof Gerda Morlock 2013-02-26
Ionicon–Austria (govt): grant, 201302 support funding for developm of PTR-ToF-MS for NASA project from bmvit within ASAP 8 2013-02-22
Ionicon–Univ Innsbruck: mass spectrometry, 201302 collab developm PTR-ToF-MS for NASA project 2013-02-22
United States (govt)–Ionicon: mass spectrometer, 201302 supply use of PTR-ToF-MS by NASA project to measure air pollution 2013-02-22
LUM GmbH–Germany (govt): centrifuge technology, 201302 license existent from BAM 2013-02-19
Daiichi Sankyo–Affimed: cancer antibodies, 201302– collab €na research using AbSieve discovery platform of AbCheck + U3 Pharma 2013-02-18
Roche–Chiasma: octreotide, 201302– collab developm ww excl license to commercialise Octreolin $65m upfront + $530m milestones + royalties 2013-02-18
Apeiron–Austria (govt): grant, 201302– FFG funding of up to €745k for development of APN411 2013-02-14
Boehringer–ChemAxon: cheminformatics, 201302– supply ww of ChemAxon chemistry s/w platform 2013-02-14
BioTag–Medicyte: cell technology, 201302– distribution of upcyte technology + cells in Israel by BioTag Ltd 2013-02-13
Blue Stream Laboratories–Thermo Fisher: mass spectrometer, 201302 supply purchase Thermo TSQ Vantage Triple Stage Quadrupole system 2013-02-13
MorphoSys–Heptares: therapeutic antibodies, 201302– collab strategic alliance RnD GPCR-antibodies using STaR technology + Ylanthia 2013-02-13
Westburg–Medicyte: cell technology, 201302– distribution of upcyte + vericyte technology + products in Benelux by Westburg BV 2013-02-13
Innovative Medicines Initiative–Max Planck: drug discovery, 201302– collab Lead Discovery Center GmbH is partner of European Lead Factory project 2013-02-12
B-Bridge–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products for Japan 2013-02-08
B-Bridge–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products for North America 2013-02-08
Apogenix–MC Services: public relations, 201302 service existent for Apogenix GmbH 2013-02-07
Ono Pharmaceutical–Genedata: mass spectrometry s/w, 201302– license to Genedata Expressionist for Mass Spectrometry 2013-02-07
Merck (DE)–Opexa Therapeutics: imilecleucel-T, 201302– option for excl license developm + commerc of Tcelna for MS ww excl JP $5m upfront 2013-02-05
Sopat–High-Tech Gründerfonds: investment, 201302 1st financing round HTGF + Steelhouse Ventures Ltd 2013-02-04
Sopat–SEVERAL: investment, 201302 1st financing round HTGF + Steelhouse Ventures Ltd 2013-02-04
Spain (govt)–Scienion: print/spotting technology, 201302 supply use of sciFlexarrayer to produce nanobiosensors by Bionanomechanics Lab at IMM-CSIC 2013-02-04
Dynamic Biosensors–SEVERAL: investment, 201302 1st financing round Bayern Kapital + BioM + Extorel + TUM-Fonds 2013-02-01
Epigenomics–Van Lanschot: investment, 201302 DIVESTMENT F van Lanschot Bankiers NV sells all 26.32% shares owned 2013-02-01
Innovative Medicines Initiative–Bayer: drug discovery, 201302– collab Bayer HealthCare is coordinating partner of European Lead Factory project 2013-02-01
Innovative Medicines Initiative–EU (govt): grant, 201302– funding support €80m for European Lead Factory project via FP7 2013-02-01
PharmaSea project–EU (govt): grant, 201302–201701 FP7 grant €9.5m 2013-02-01
Epigenomics–Abingworth: investment, 201301 existent Abingworth Bioventures V owns 14.43% of voting rights 2013-01-29
Zytoprotec–Baxter: investment, 201301 financing €2m from new investor Baxter Ventures 2013-01-29
Advanova–High-Tech Gründerfonds: investment, 201301 1st financing round HTGF + BayernKapital + consortium of business angels 2013-01-28
Advanova–SEVERAL: investment, 201301 1st financing round HTGF + BayernKapital + consortium of business angels 2013-01-28
AstraZeneca–Max Planck: drug discovery services, 201301–201412 collab screening of 250k compounds from AZ against targets from LDC partners at LDC 2013-01-25
Cytos Biotechnology–SA Noonan Communications: public relations, 201301 service existent 2013-01-23
DPPN–Germany (govt): grant, 2001301–201712 support €35m for 5 years from BMBF 2013-01-23
Lophius–SEVERAL: investment, 201301 financing round €4m VRD GmbH + WIC GmbH + S-Refit + HTGF + Bayern Kapital + 2 business angels 2013-01-22
Applied Microarrays–Schott: microarray slides, 201301– distribution of Nexterion products in US + Canada by AMI 2013-01-21
Ayoxxa–National Univ Singapore: protein micorarray technology, 201301– collab r+d IEBA technology with Dept of Bioengineering at NUS 2013-01-21
Ayoxxa–SEVERAL: investment, 201301 financing round Series A 2nd Closing €0.4m incl new investor KfW Bankengruppe 2013-01-21
Global Alliance of Leading Drug Discovery & Development Centres–Max Planck: drug discovery, 201301– LDC is founding member 2013-01-21
Markes International–Schauenburg: investment, 201301 acquisition of majority share by Schauenburg International 2013-01-16
Paladin Labs–Apeiron: APN311, 201301– license excl €na to market + sell APN311 in Canada + Sub-Saharan Africa incl South Africa 2013-01-16
Leibniz-Gemeinschaft–Wiley: investment, 201301 acquisition of the assets of FIZ Chemie from German govt + Berlin govt et al 2013-01-15
Boehringer–Horizon Discovery: drug discovery services, 201301– collab 5 years €na supply of services using X-MAN + GENESIS technologies in oncology 2013-01-14
pH (IT)–TÜV Süd: investment, 201301 aquisition 100% of pH s.r.l. 2013-01-11
Evotec–Yale Univ: drug discovery, 201301– strategic partnership to combine Evotec drug discovery infrastructure with Yale research 2013-01-09
Spinomix–Debiopharm: investment, 201301 financing round Series A $3m led by Debiopharm 2013-01-09
Spinomix–SEVERAL: investment, 201301 financing round Series A $3m led by Debiopharm 2013-01-09
STATegra project–Biomax: bioinformatics, 201301– Biomax Informatics AG is project member 2013-01-09
Prophyta–Bayer: investment, 201301 acquisition €na by Bayer CropScience 2013-01-08
AstraZeneca–Evotec: antidiabetics, 201301– collab + license agreem expansion + extension until end of 2013 with MedImmune 2013-01-07
Drug Response Dx–High-Tech Gründerfonds: investment, 201301 1st financing round with Qiagen + HTGF 2013-01-07
Drug Response Dx–Qiagen: investment, 201301 1st financing round with Qiagen + High-Tech Gründerfonds 2013-01-07
Drug Response Dx–SEVERAL: investment, 201301 1st financing round with Qiagen + High-Tech Gründerfonds 2013-01-07
GSK–Priaxon: drug discovery services, 201301– supply service €na to identify + develop small molecule modulators of protein-protein-interactions 2013-01-07
ISA Pharmaceuticals–Akampion: public relations, 201301 service existent 2013-01-07
Qiagen–Drug Response Dx: genomic biomarker, 201301– license option ww rights to biomarkers for companion tests for TNA-alpha inhibitors for RA 2013-01-07
Qiagen–France (govt): genomic biomarker, 201301– license excl ww mutations of HSP110 gene for PDx in colorectal cancer from Inserm 2013-01-07
Qiagen–Insight Genetics: genomic biomarker, 201301– license excl ww for genetic test incl 3 new markers for PDx in lung cancer 2013-01-07
Shire–Ethris: RNA-based therapeutics, 201301– collab €na developm + commercialisation of RNA therapeutics using SNIM technology 2013-01-07
Bruker Corp–Erasmus Univ: clinical diagnostics, 201301– license excl for MALDI-TOF-based beta-lactamase testing from EMC 2013-01-03
CCS Cell Culture Service–Evotec: investment, 201301 acquisition 100% for €1.15m in cash upfront + 1 year-milestone of €1.05 in cash 2013-01-03
Cevec–Deutsche Stiftung Impfstoffforschung: vaccine technology, 201301– license excl to CMV dense body techn for developm of CMV vaccine from VPM 2013-01-03
Apeiron–Evotec: cancer immunotherapy, 201301– collab €na development of lead compounds 2013-01-02
ABF–Genedata: bioinformatics, 2013– supply use of Genedata Selector by AB Enzymes for strain genome data management 2013-01-01
Apceth–Germany (govt): grant, 201301–201503 2nd of 2 funding phases within m4 Cluster from BMBF w total €4.7m for both phases 2013-01-01
BioNTech–4SC: drug discovery services, 201301–201512 collab service identification + optimisation of small-molecular cancer drugs by 4SC Discovery 2013-01-01
next pagenext page 1 2 3 ... 33 34 35 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top